neuroCare Group

neuroCare is innovating mental health and performance. It is the first digital therapeutics (DTx) platform of its kind empowering clinicians to deliver best practice. Following a detailed assessment we develop personalised therapy and performance plans that lead to best and most sustainable outcomes. neuroCare's objective and measurable approach is based on our natural ability to learn (neuroplasticity) adding technology and clinical SOP's to speed up that learning. Because this approach enables individuals to improve their self-regulation it is a sustainable solution. Our leading response rates are published in reputated scientific journals. There is a huge need with over 800 million people suffering from mental health issues and hundreds of millions suffering from sleeping issues. Performance and stress management for high performing individuals are also largely untapped markets. neurocare is a true impact investment, ready to be scaled fast to match a significant increase in demand due to the COVID pandemic.